 SOUTH SAN FRANCISCO, Calif., Oct. 06, 2021 GLOBE NEWSWIRE -- Assembly Biosciences, Inc. Nasdaq: ASMB, a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus HBV, announced participation in the below upcoming conferences focused on HBV: 